Besides, nanostructured lipid carrier-oleuropein was tested in the DSS-induced colitis experimental model and it exhibited a modulation of the inflammatory biomarkers via decreasing the level of TNF-α, IL-6, and hindering neutrophil infiltration (68). Here, IL6 is linked to colitis.